30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Shawn McCormick

Track

Insider profile

Currently holds positions in Nevro Corp, Surmodics Inc and Inspire Medical Systems Inc

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 17% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Nevro Corp Sept. 1, 2014 -
Independent Director Surmodics Inc Dec. 18, 2015 -
Independent Director Inspire Medical Systems Inc Jan. 1, 2017 -
Independent Director Entellus Medical Inc Nov. 1, 2014 - Feb. 28, 2018
Chief Financial Officer Wright Medical Group NV Sept. 4, 2012 - Oct. 1, 2015
Shawn McCormick's trades of Inspire Medical Systems Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-11 2026-05-08
S Sale
65,672 -23.2%
306.21
US$4,810,674 		65,672 -23.2% 306.21 US$4,810,674
2026-05-08 2026-05-08
PrS Proposed sale
88,167
213.70
US$2,376,804 		88,167 213.70 US$2,376,804
2025-12-04 2025-12-02
S Sale
90,543 +22.8%
439.27
US$49,071 		90,543 +22.8% 439.27 US$49,071
2025-12-02 2025-12-02
PrS Proposed sale
1,200
126.34
US$151,608 		1,200 126.34 US$151,608
2025-12-01 2025-11-28
S Sale
2,000 -7.1%
127.48
US$254,960 		2,000 -7.1% 127.48 US$254,960
2025-11-28 2025-11-28
PrS Proposed sale
2,000
127.33
US$254,660 		2,000 127.33 US$254,660
2025-05-05 2025-05-02
S Sale
360 -1.5%
160.00
US$57,600 		360 -1.5% 160.00 US$57,600
2025-05-02 2025-05-02
PrS Proposed sale
360
157.90
US$56,844 		360 157.90 US$56,844
2024-09-11 2024-09-09
S Sale
800 -3.3%
220.00
US$176,000 		800 -3.3% 220.00 US$176,000
2024-09-09 2024-09-09
PrS Proposed sale
800
220.00
US$176,000 		800 220.00 US$176,000
2023-06-09 2023-06-07
US Nevro Corp (NVRO)
B Purchase
7,500 +38.7%
22.88
US$171,633 		7,500 +38.7% 22.88 US$171,633
2021-05-26 2021-05-24
US Nevro Corp (NVRO)
PlS Planned sale
482 -6.2%
149.65
US$72,131 		482 -6.2% 149.65 US$72,131
2020-06-30 2020-06-30
S Sale
1,329,186
0.03
£39,876 		1,329,186 0.03 £39,876
2020-05-26 2020-05-21
US Nevro Corp (NVRO)
PlS Planned sale
1,020 -11.6%
126.50
US$129,030 		1,020 -11.6% 126.50 US$129,030